DIFFERENCES BETWEEN FASTING BLOOD GLUCOSE LEVELS IN THE ACCEPTORS OF THREE MONTHLY (DMPA) AND CONTRACEPTIVE INJECTIONS ACCEPTOR MONTHLY (CYCLOFEM)

Abstract

ABSTRACT

The use of three-monthly injection contrast containing the hormone progesterone has an effect on increasing blood glucose levels. Increased blood glucose levels can cause Diabetes Mellitus. This study aims to measure blood glucose levels in three-monthly injection acceptors (DMPA) with one-month injection acceptors. This research is an observational study with a cross sectional design. This research was conducted at Puskesmas Lubuk Buaya Padang and in the Laboratory of the Biochemistry Section of the Faculty of Medicine, Andalas University from September 2018 - January 2019. The subjects of this study consisted of two groups, namely three-monthly injection (DMPA) acceptors and one-monthly injection (Cyclofem), respectively. each consisted of 33 samples. Examination of fasting blood glucose levels was carried out using the enzymatic calorimetric method (hexokinase). Data were analyzed using t test with p <0.05 was considered statistically significant. The results showed that the average fasting blood glucose level between the three monthly injection acceptors (DMPA) was 109.06 ± 3.54 mg / dl and the one-month injection (Cyclofem) was 101.89 ± 3.54 with p value = 0.158 which means p> 0.05.The conclusion of this study was that there was no significant difference in the mean fasting blood glucose levels between the three-monthly injection acceptors (DMPA) and the one-month injection acceptors (cyclofem).

Keywords: fasting blood glucose, three monthly injections (DMPA), one month (cyclofem)